SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-012827
Filing Date
2015-02-27
Accepted
2015-02-27 16:40:53
Documents
2
Period of Report
2015-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 v403146_4.html 4  
1 FORM 4 v403146_4.xml 4 4081
2 EXHIBIT 24 v403146_ex24.htm EX-24 7708
  Complete submission text file 0001144204-15-012827.txt   13277
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., STE 306 NEW YORK NY 10022
Business Address
GERSHELL LELAND (Reporting) CIK: 0001563615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 15659824